Free Trial

Anterix (ATEX) Financials

Anterix logo
$27.69 +0.59 (+2.18%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$27.69 0.00 (0.00%)
As of 05/27/2025 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Anterix

Annual Income Statements for Anterix

This table shows Anterix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 3/31/2024 3/31/2023 3/31/2022
Net Income / (Loss) Attributable to Common Shareholders
-9.13 -16 -38
Consolidated Net Income / (Loss)
-9.13 -16 -38
Net Income / (Loss) Continuing Operations
-9.13 -16 -38
Total Pre-Tax Income
-7.52 -15 -37
Total Operating Income
-10 -16 -37
Total Gross Profit
4.19 1.92 1.08
Total Revenue
4.19 1.92 1.08
Operating Revenue
4.19 1.92 1.08
Total Cost of Revenue
0.00 0.00 0.01
Total Operating Expenses
14 18 38
Selling, General & Admin Expense
44 45 40
Marketing Expense
5.69 5.73 4.46
Research & Development Expense
5.70 4.44 3.59
Depreciation Expense
0.84 1.42 1.45
Other Special Charges / (Income)
-42 -38 -11
Total Other Income / (Expense), net
2.61 1.41 0.31
Interest & Investment Income
2.37 1.14 0.06
Other Income / (Expense), net
0.23 0.27 0.26
Income Tax Expense
1.61 1.26 0.98
Basic Earnings per Share
($0.49) ($0.87) ($2.07)
Weighted Average Basic Shares Outstanding
18.77M 18.84M 18.14M
Diluted Earnings per Share
($0.49) ($0.87) ($2.07)
Weighted Average Diluted Shares Outstanding
18.77M 18.84M 18.14M
Weighted Average Basic & Diluted Shares Outstanding
18.57M 19.04M 18.93M

Quarterly Income Statements for Anterix

This table shows Anterix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2024 12/31/2024 9/30/2023 6/30/2024 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Net Income / (Loss) Attributable to Common Shareholders
-9.41 7.71 2.07 -16 16 -8.02 -11 -13 -11 -13
Consolidated Net Income / (Loss)
-9.41 7.71 2.07 -16 16 -8.02 -11 -13 -11 -13
Net Income / (Loss) Continuing Operations
-9.41 7.71 2.07 -16 16 -8.02 -11 -13 -11 -13
Total Pre-Tax Income
-9.54 7.48 2.72 -14 16 -7.81 -10 -13 -11 -12
Total Operating Income
-11 7.03 2.26 -15 16 -8.40 -11 -13 -11 -12
Total Gross Profit
1.26 1.57 1.05 1.53 0.61 0.58 0.40 0.34 0.34 0.38
Total Revenue
1.26 1.57 1.05 1.53 0.61 0.58 0.40 0.34 0.34 0.39
Operating Revenue
1.26 1.57 1.05 1.53 0.61 0.58 0.40 0.34 0.34 0.39
Total Operating Expenses
12 -5.47 -1.21 17 -15 8.98 11 13 11 13
Selling, General & Admin Expense
9.59 9.20 12 13 10 12 11 11 9.75 10
Marketing Expense
1.73 1.31 1.31 1.85 1.95 1.39 1.16 1.24 1.15 1.26
Research & Development Expense
2.24 1.12 1.15 1.75 1.43 0.94 0.98 1.10 0.77 0.89
Depreciation Expense
0.19 0.14 0.21 0.18 0.31 0.37 0.37 0.36 0.45 0.32
Other Special Charges / (Income)
-1.98 -21 -16 - -29 -5.80 -2.89 -0.65 -0.98 0.06
Total Other Income / (Expense), net
0.97 0.44 0.46 0.71 0.50 0.59 0.23 0.08 0.06 0.07
Interest & Investment Income
0.93 0.43 0.40 0.69 0.47 0.41 0.24 0.02 0.00 0.01
Other Income / (Expense), net
0.04 0.01 0.06 0.02 0.03 0.19 -0.01 0.06 0.06 0.06
Income Tax Expense
-0.13 -0.23 0.65 1.22 0.64 0.21 0.22 0.20 0.27 0.41
Basic Earnings per Share
($0.51) $0.41 $0.11 ($0.84) $0.82 ($0.42) ($0.56) ($0.71) ($0.60) ($0.69)
Weighted Average Basic Shares Outstanding
18.77M 18.61M 18.92M 18.49M 18.84M 18.93M 18.95M 18.62M 18.14M 18.31M
Diluted Earnings per Share
($0.51) $0.41 $0.11 ($0.84) $0.82 ($0.42) ($0.56) ($0.71) ($0.60) ($0.69)
Weighted Average Diluted Shares Outstanding
18.77M 18.78M 19.11M 18.49M 18.84M 18.93M 18.95M 18.62M 18.14M 18.31M
Weighted Average Basic & Diluted Shares Outstanding
18.57M 18.59M 18.62M 18.59M 19.04M 18.87M 18.96M 18.94M 18.93M 18.31M

Annual Cash Flow Statements for Anterix

This table details how cash moves in and out of Anterix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 3/31/2024 3/31/2023 3/31/2022
Net Change in Cash & Equivalents
25 -62 -12
Net Cash From Operating Activities
42 -27 18
Net Cash From Continuing Operating Activities
42 -27 18
Net Income / (Loss) Continuing Operations
-9.13 -16 -38
Consolidated Net Income / (Loss)
-9.13 -16 -38
Depreciation Expense
0.84 1.42 1.45
Non-Cash Adjustments To Reconcile Net Income
-28 -20 2.16
Changes in Operating Assets and Liabilities, net
78 8.12 52
Net Cash From Investing Activities
8.09 -27 -27
Net Cash From Continuing Investing Activities
8.09 -27 -27
Purchase of Property, Plant & Equipment
-0.31 -2.13 -1.05
Acquisitions
-17 -25 -26
Divestitures
25 0.00 -
Net Cash From Financing Activities
-25 -8.06 -2.42
Net Cash From Continuing Financing Activities
-25 -8.06 -2.42
Repurchase of Common Equity
-25 -8.22 -15
Other Financing Activities, net
-0.46 0.16 13

Quarterly Cash Flow Statements for Anterix

This table details how cash moves in and out of Anterix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Net Change in Cash & Equivalents
-1.43 21 14 -14 -14 -13 -16 -19 -22 27
Net Cash From Operating Activities
6.14 34 4.57 -8.21 -8.57 -0.73 -8.12 -9.83 -9.12 40
Net Cash From Continuing Operating Activities
6.14 34 4.57 -8.21 -8.57 -0.73 -8.12 -9.83 -9.12 40
Net Income / (Loss) Continuing Operations
-9.41 0.33 15 -2.12 16 -8.02 -11 -13 -11 -13
Consolidated Net Income / (Loss)
-9.41 0.33 15 -2.12 16 -8.02 -11 -13 -11 -13
Depreciation Expense
0.19 0.20 0.28 0.25 0.31 0.37 0.37 0.36 0.45 0.32
Non-Cash Adjustments To Reconcile Net Income
1.40 -9.95 -23 -7.19 -24 -1.29 1.93 3.18 3.31 3.28
Changes in Operating Assets and Liabilities, net
14 43 12 0.85 -0.15 8.21 0.47 -0.42 -1.03 48
Net Cash From Investing Activities
-2.26 -4.54 20 -5.20 -6.52 -8.24 -5.72 -6.66 -11 -4.21
Net Cash From Continuing Investing Activities
-2.26 -4.54 20 -5.20 -6.52 -8.24 -5.72 -6.66 -11 -4.21
Purchase of Property, Plant & Equipment
-0.04 -0.06 -0.21 -0.03 -0.58 -0.40 -1.14 -0.01 -0.80 -0.04
Acquisitions
-2.22 -4.73 -4.68 -5.17 -5.94 -7.84 -4.58 -6.65 -10 -4.16
Net Cash From Financing Activities
-5.30 -8.09 -11 -0.75 0.76 -3.64 -2.51 -2.68 -1.89 -8.53
Net Cash From Continuing Financing Activities
-5.30 -8.09 -11 -0.75 0.76 -3.64 -2.51 -2.68 -1.89 -8.53
Repurchase of Common Equity
-5.97 -7.97 -8.71 0.00 - -3.50 -2.00 -2.73 -2.97 -12
Other Financing Activities, net
0.67 -0.12 -1.97 -0.75 0.76 -0.14 -0.51 0.05 1.08 3.47

Annual Balance Sheets for Anterix

This table presents Anterix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 3/31/2024 3/31/2023 3/31/2022
Total Assets
325 279 278
Total Current Assets
73 59 116
Cash & Equivalents
61 43 106
Prepaid Expenses
3.91 2.44 10
Other Current Assets
8.52 14 -
Plant, Property, & Equipment, net
2.06 3.61 2.95
Total Noncurrent Assets
250 215 159
Intangible Assets
217 202 151
Other Noncurrent Operating Assets
33 13 8.16
Total Liabilities & Shareholders' Equity
325 279 278
Total Liabilities
164 99 92
Total Current Liabilities
18 32 9.64
Short-Term Debt
1.00 20 0.00
Accounts Payable
8.63 6.62 6.65
Accrued Expenses
0.00 - -
Current Deferred Revenue
6.47 2.77 1.48
Other Current Liabilities
1.85 2.26 1.51
Total Noncurrent Liabilities
146 67 82
Noncurrent Deferred Revenue
116 58 53
Noncurrent Deferred & Payable Income Tax Liabilities
6.28 5.44 4.19
Other Noncurrent Operating Liabilities
24 3.44 25
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
161 180 186
Total Preferred & Common Equity
161 180 186
Preferred Stock
0.00 0.00 0.00
Total Common Equity
161 180 186
Common Stock
533 518 500
Retained Earnings
-372 -338 -314

Quarterly Balance Sheets for Anterix

This table presents Anterix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 12/31/2022 9/30/2022 6/30/2022 12/31/2021
Total Assets
327 317 321 258 256 264 288
Total Current Assets
40 57 66 72 82 98 135
Cash & Equivalents
29 43 52 58 70 86 128
Prepaid Expenses
3.14 1.58 2.97 15 12 12 7.27
Other Current Assets
8.35 12 11 - - - -
Plant, Property, & Equipment, net
1.58 1.73 1.84 3.34 3.32 2.59 2.64
Total Noncurrent Assets
285 259 254 182 171 163 150
Intangible Assets
246 222 220 170 159 155 144
Other Noncurrent Operating Assets
39 37 34 12 11 8.60 5.93
Total Liabilities & Shareholders' Equity
327 317 321 258 256 264 288
Total Liabilities
182 178 172 99 90 90 92
Total Current Liabilities
24 16 17 31 30 8.97 9.87
Short-Term Debt
5.40 1.00 1.00 20 20 - -
Accounts Payable
9.01 7.09 7.75 6.68 5.51 5.21 6.94
Accrued Expenses
2.29 - - - - - -
Current Deferred Revenue
5.96 5.92 5.97 2.66 2.51 2.19 1.48
Other Current Liabilities
1.75 1.81 1.81 1.75 1.63 1.57 1.45
Total Noncurrent Liabilities
158 162 156 67 60 81 83
Noncurrent Deferred Revenue
120 121 115 59 51 52 54
Noncurrent Deferred & Payable Income Tax Liabilities
6.74 7.67 7.34 4.81 4.60 4.39 3.92
Other Noncurrent Operating Liabilities
31 34 34 3.73 3.92 24 25
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
145 139 149 159 166 175 196
Total Preferred & Common Equity
145 139 149 159 166 175 196
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
145 139 149 159 166 175 196
Common Stock
544 542 539 513 508 504 495
Retained Earnings
-399 -402 -390 -354 -342 -330 -300

Annual Metrics And Ratios for Anterix

This table displays calculated financial ratios and metrics derived from Anterix's official financial filings.

Metric 2024 2023 2022
Period end date 3/31/2024 3/31/2023 3/31/2022
Growth Metrics
- - -
Revenue Growth
118.40% 77.03% 17.70%
EBITDA Growth
38.78% 57.96% 30.91%
EBIT Growth
38.94% 55.74% 32.73%
NOPAT Growth
38.51% 55.33% 32.77%
Net Income Growth
44.06% 56.51% 31.07%
EPS Growth
43.68% 57.97% 33.87%
Operating Cash Flow Growth
254.10% -252.12% 279.87%
Free Cash Flow Firm Growth
155.09% -662.84% 55.37%
Invested Capital Growth
-35.32% 94.44% -15.05%
Revenue Q/Q Growth
18.42% 16.59% 54.42%
EBITDA Q/Q Growth
-152.43% 64.04% 2.02%
EBIT Q/Q Growth
-160.72% 62.03% 1.04%
NOPAT Q/Q Growth
-150.74% 61.67% 1.10%
Net Income Q/Q Growth
-157.68% 61.94% -0.22%
EPS Q/Q Growth
-158.33% 62.01% 0.96%
Operating Cash Flow Q/Q Growth
53.94% 1.98% -52.54%
Free Cash Flow Firm Q/Q Growth
97.26% -4.46% -168.74%
Invested Capital Q/Q Growth
-8.79% 28.82% 18.88%
Profitability Metrics
- - -
Gross Margin
100.00% 100.00% 99.54%
EBITDA Margin
-215.82% -769.93% -3,241.88%
Operating Margin
-241.52% -857.79% -3,399.26%
EBIT Margin
-235.96% -843.93% -3,375.65%
Profit (Net Income) Margin
-217.80% -850.29% -3,461.16%
Tax Burden Percent
121.46% 108.38% 102.69%
Interest Burden Percent
75.99% 92.96% 99.85%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-5.49% -9.70% -29.37%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.53% -2.24% -18.86%
Return on Net Nonoperating Assets (RNNOA)
0.13% 0.79% 10.55%
Return on Equity (ROE)
-5.36% -8.91% -18.82%
Cash Return on Invested Capital (CROIC)
37.41% -73.85% -13.09%
Operating Return on Assets (OROA)
-3.28% -5.82% -13.78%
Return on Assets (ROA)
-3.03% -5.86% -14.13%
Return on Common Equity (ROCE)
-5.36% -8.91% -18.82%
Return on Equity Simple (ROE_SIMPLE)
-5.67% -9.08% -20.14%
Net Operating Profit after Tax (NOPAT)
-7.09 -12 -26
NOPAT Margin
-169.06% -600.45% -2,379.48%
Net Nonoperating Expense Percent (NNEP)
-4.95% -7.46% -10.51%
Cost of Revenue to Revenue
0.00% 0.00% 0.46%
SG&A Expenses to Revenue
1,059.96% 2,354.19% 3,646.22%
R&D to Revenue
135.93% 231.32% 331.46%
Operating Expenses to Revenue
341.52% 957.79% 3,498.80%
Earnings before Interest and Taxes (EBIT)
-9.89 -16 -37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-9.05 -15 -35
Valuation Ratios
- - -
Price to Book Value (P/BV)
3.87 3.47 5.71
Price to Tangible Book Value (P/TBV)
0.00 0.00 30.29
Price to Revenue (P/Rev)
148.52 324.87 981.47
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
5.55 3.83 11.88
Enterprise Value to Revenue (EV/Rev)
134.31 312.92 884.03
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
13.40 0.00 53.50
Enterprise Value to Free Cash Flow (EV/FCFF)
11.65 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
0.01 0.11 0.00
Long-Term Debt to Equity
0.00 0.00 0.00
Financial Leverage
-0.24 -0.35 -0.56
Leverage Ratio
1.77 1.52 1.33
Compound Leverage Factor
1.35 1.41 1.33
Debt to Total Capital
0.62% 10.12% 0.00%
Short-Term Debt to Total Capital
0.62% 10.12% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
99.38% 89.88% 100.00%
Debt to EBITDA
-0.11 -1.37 0.00
Net Debt to EBITDA
6.59 1.55 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00
Debt to NOPAT
-0.14 -1.76 0.00
Net Debt to NOPAT
8.41 1.99 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00
Altman Z-Score
0.79 2.02 5.41
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
4.07 1.86 12.01
Quick Ratio
3.37 1.35 10.96
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
48 -88 -11
Operating Cash Flow to CapEx
13,678.50% -1,281.75% 1,701.14%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00
Efficiency Ratios
- - -
Asset Turnover
0.01 0.01 0.00
Accounts Receivable Turnover
0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00
Fixed Asset Turnover
1.48 0.59 0.33
Accounts Payable Turnover
0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 476,471.00
Cash Conversion Cycle (CCC)
0.00 0.00 -476,471.00
Capital & Investment Metrics
- - -
Invested Capital
101 157 81
Invested Capital Turnover
0.03 0.02 0.01
Increase / (Decrease) in Invested Capital
-55 76 -14
Enterprise Value (EV)
563 600 958
Market Capitalization
622 623 1,064
Book Value per Share
$8.70 $9.53 $10.14
Tangible Book Value per Share
($3.01) ($1.18) $1.91
Total Capital
162 200 186
Total Debt
1.00 20 0.00
Total Long-Term Debt
0.00 0.00 0.00
Net Debt
-60 -23 -106
Capital Expenditures (CapEx)
0.31 2.13 1.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-4.52 4.63 0.51
Debt-free Net Working Capital (DFNWC)
56 48 106
Net Working Capital (NWC)
55 28 106
Net Nonoperating Expense (NNE)
2.04 4.79 12
Net Nonoperating Obligations (NNO)
-60 -23 -106
Total Depreciation and Amortization (D&A)
0.84 1.42 1.45
Debt-free, Cash-free Net Working Capital to Revenue
-107.80% 241.06% 47.14%
Debt-free Net Working Capital to Revenue
1,337.63% 2,491.30% 9,791.05%
Net Working Capital to Revenue
1,313.77% 1,436.11% 9,791.05%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
($0.49) ($0.87) ($2.07)
Adjusted Weighted Average Basic Shares Outstanding
18.77M 18.84M 18.14M
Adjusted Diluted Earnings per Share
($0.49) ($0.87) ($2.07)
Adjusted Weighted Average Diluted Shares Outstanding
18.77M 18.84M 18.14M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
18.57M 19.04M 18.93M
Normalized Net Operating Profit after Tax (NOPAT)
-37 -38 -34
Normalized NOPAT Margin
-876.31% -2,000.78% -3,096.40%
Pre Tax Income Margin
-179.31% -784.52% -3,370.48%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
-270.33% -50.40% -39.88%

Quarterly Metrics And Ratios for Anterix

This table displays calculated financial ratios and metrics derived from Anterix's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2024 12/31/2024 9/30/2024 6/30/2024 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Growth Metrics
- - - - - - - - - -
Revenue Growth
107.24% 170.93% 289.70% 355.22% 81.49% 50.13% 118.68% 84.07% 812.77% -18.43%
EBITDA Growth
-164.14% 192.28% -24.80% -19.37% 255.69% 33.07% -898.06% -10.32% 6.58% -7.22%
EBIT Growth
-166.63% 185.68% -23.03% -15.24% 246.20% 33.24% -548.75% -9.44% 3.47% -2.99%
NOPAT Growth
-148.86% 223.28% -23.17% -14.84% 299.10% 32.09% -524.49% -9.28% 3.65% -2.58%
Net Income Growth
-160.55% 196.13% -19.95% -17.64% 241.07% 36.92% -498.93% -9.88% -0.75% -5.18%
EPS Growth
-162.20% 197.62% -23.21% -18.31% 236.67% 39.13% -460.00% -4.41% 3.23% 0.00%
Operating Cash Flow Growth
171.61% 4,720.88% 156.36% 75.99% 6.03% -101.84% -177.09% -1.75% -185.19% 768.51%
Free Cash Flow Firm Growth
178.60% 112.83% 189.59% -503.23% -1,007.86% -275.11% -343.31% 104.59% 41.61% 341.48%
Invested Capital Growth
-35.32% -0.34% -16.60% 11.32% 94.44% 79.43% 3.39% -13.91% -15.05% -38.68%
Revenue Q/Q Growth
-0.87% 0.97% 155.10% 150.82% 5.19% 45.23% 18.81% 0.00% -12.99% 111.54%
EBITDA Q/Q Growth
-957.76% 156.32% -414.57% -192.48% 304.21% 23.83% 17.02% -20.62% 12.22% -1,035.95%
EBIT Q/Q Growth
-1,146.70% 153.63% -378.50% -195.46% 291.13% 22.99% 17.99% -21.11% 12.73% -648.45%
NOPAT Q/Q Growth
-3,956.73% 178.90% -362.49% -169.79% 355.96% 21.16% 18.45% -20.99% 12.69% -624.96%
Net Income Q/Q Growth
-2,969.21% 160.39% -502.74% -199.88% 293.79% 24.65% 19.35% -19.78% 13.35% -615.53%
EPS Q/Q Growth
-2,650.00% 159.42% -527.27% -202.44% 295.24% 25.00% 21.13% -18.33% 13.04% -590.00%
Operating Cash Flow Q/Q Growth
-81.75% 635.46% 293.73% 72.46% -1,077.75% 91.03% 17.45% -7.76% -123.02% 1,452.99%
Free Cash Flow Firm Q/Q Growth
348.10% -24.05% 184.43% 66.49% -2.25% -430.35% -321.93% -24.56% -80.28% 1,442.66%
Invested Capital Q/Q Growth
-8.79% 25.18% -1.16% -37.48% 28.82% 4.77% 31.93% 9.20% 18.88% -39.63%
Profitability Metrics
- - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.70%
EBITDA Margin
-815.56% 462.32% -828.76% -971.61% 2,635.20% -1,357.44% -2,587.94% -3,705.37% -3,071.94% -3,044.94%
Operating Margin
-834.21% 449.04% -846.55% -984.39% 2,578.13% -1,453.98% -2,678.39% -3,902.09% -3,225.07% -3,214.29%
EBIT Margin
-830.71% 449.68% -846.55% -983.34% 2,583.72% -1,421.97% -2,681.41% -3,884.48% -3,207.46% -3,197.92%
Profit (Net Income) Margin
-746.90% 492.34% -823.08% -1,017.97% 2,556.25% -1,387.54% -2,674.12% -3,939.10% -3,288.66% -3,302.60%
Tax Burden Percent
98.64% 103.13% 101.83% 108.54% 96.06% 102.69% 102.06% 101.54% 102.54% 103.35%
Interest Burden Percent
91.15% 106.16% 95.48% 95.37% 102.99% 95.02% 97.71% 99.87% 99.99% 99.93%
Effective Tax Rate
0.00% -3.13% 0.00% 0.00% 3.94% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-18.95% 14.61% -18.60% -16.23% 40.02% -17.67% -23.83% -35.49% -27.87% -17.70%
ROIC Less NNEP Spread (ROIC-NNEP)
-13.97% 13.10% -10.83% -8.91% 39.26% -15.08% -19.61% -31.30% -24.77% -14.26%
Return on Net Nonoperating Assets (RNNOA)
3.38% -2.62% 3.26% 3.78% -13.79% 7.02% 7.79% 15.77% 13.86% 8.13%
Return on Equity (ROE)
-15.57% 11.99% -15.33% -12.45% 26.23% -10.65% -16.04% -19.72% -14.00% -9.57%
Cash Return on Invested Capital (CROIC)
37.41% 17.93% 12.39% -15.40% -73.85% -88.56% -32.06% -12.96% -13.09% 18.74%
Operating Return on Assets (OROA)
-11.54% 5.90% -9.88% -7.36% 17.82% -8.58% -15.20% -18.75% -13.09% -8.48%
Return on Assets (ROA)
-10.37% 6.46% -9.61% -7.62% 17.63% -8.37% -15.16% -19.02% -13.42% -8.76%
Return on Common Equity (ROCE)
-15.57% 11.99% -15.33% -12.45% 26.23% -10.65% -16.04% -19.72% -14.00% -9.57%
Return on Equity Simple (ROE_SIMPLE)
0.00% 16.03% -5.29% -3.52% 0.00% -26.96% -28.64% -22.17% 0.00% -19.14%
Net Operating Profit after Tax (NOPAT)
-7.36 7.25 -9.19 -11 15 -5.88 -7.46 -9.15 -7.56 -8.66
NOPAT Margin
-583.94% 463.10% -592.59% -689.08% 2,476.62% -1,017.79% -1,874.87% -2,731.46% -2,257.55% -2,250.00%
Net Nonoperating Expense Percent (NNEP)
-4.98% 1.51% -7.77% -7.31% 0.75% -2.59% -4.22% -4.18% -3.10% -3.43%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.30%
SG&A Expenses to Revenue
761.35% 587.68% 734.82% 842.69% 1,695.07% 2,090.83% 2,871.11% 3,390.75% 2,910.75% 2,654.29%
R&D to Revenue
178.02% 71.52% 114.51% 114.75% 234.70% 161.94% 246.23% 327.16% 228.96% 231.95%
Operating Expenses to Revenue
934.21% -349.04% 946.55% 1,090.49% -2,478.13% 1,553.98% 2,778.39% 4,002.09% 3,325.07% 3,312.99%
Earnings before Interest and Taxes (EBIT)
-10 7.04 -13 -15 16 -8.22 -11 -13 -11 -12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-10 7.24 -13 -15 16 -7.85 -10 -12 -10 -12
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
3.87 3.95 5.04 4.94 3.47 3.84 4.07 4.46 5.71 5.52
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 102.22 39.53 30.29 21.09
Price to Revenue (P/Rev)
148.52 148.94 209.35 335.38 324.87 370.55 465.72 628.63 981.47 1,537.34
Price to Earnings (P/E)
0.00 24.61 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 4.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
5.55 4.51 6.79 6.98 3.83 4.70 5.39 7.85 11.88 14.02
Enterprise Value to Revenue (EV/Rev)
134.31 142.83 196.76 312.25 312.92 347.92 431.40 558.74 884.03 1,355.34
Enterprise Value to EBITDA (EV/EBITDA)
0.00 23.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 24.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 25.61 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
13.40 20.07 0.00 0.00 0.00 0.00 49.92 38.95 53.50 25.21
Enterprise Value to Free Cash Flow (EV/FCFF)
11.65 25.12 49.85 0.00 0.00 0.00 0.00 0.00 0.00 56.89
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.01 0.04 0.01 0.01 0.11 0.13 0.12 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.24 -0.20 -0.30 -0.42 -0.35 -0.47 -0.40 -0.50 -0.56 -0.57
Leverage Ratio
1.77 1.92 1.88 1.81 1.52 1.54 1.35 1.34 1.33 1.28
Compound Leverage Factor
1.61 2.04 1.79 1.73 1.57 1.46 1.32 1.33 1.33 1.27
Debt to Total Capital
0.62% 3.59% 0.71% 0.67% 10.12% 11.30% 10.87% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.62% 3.59% 0.71% 0.67% 10.12% 11.30% 10.87% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
99.38% 96.41% 99.29% 99.33% 89.88% 88.71% 89.13% 100.00% 100.00% 100.00%
Debt to EBITDA
-0.11 0.23 -0.13 -0.21 -1.37 -0.49 -0.45 0.00 0.00 0.00
Net Debt to EBITDA
6.59 -1.00 5.57 10.82 1.55 0.91 1.10 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.14 0.25 -0.16 -0.23 -1.76 -0.67 -0.62 0.00 0.00 0.00
Net Debt to NOPAT
8.41 -1.09 6.92 11.63 1.99 1.24 1.52 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.79 0.31 0.61 0.90 2.40 1.88 2.76 3.69 5.71 5.93
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
4.07 1.65 3.59 3.98 1.86 2.31 2.74 10.96 12.01 13.68
Quick Ratio
3.37 1.18 2.73 3.13 1.35 1.84 2.34 9.64 10.96 12.94
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
48 7.67 10 -20 -61 -60 -11 5.08 6.73 34
Operating Cash Flow to CapEx
15,350.00% 61,163.64% 2,157.55% 0.00% -1,470.67% -182.91% -712.55% -163,866.67% -1,139.08% 92,160.47%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
1.48 1.56 1.33 0.99 0.59 0.55 0.46 0.41 0.33 0.22
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 376,643.50 378,943.00 476,471.00 526,038.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 -376,643.50 -378,943.00 -476,471.00 -526,038.00
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
101 121 97 98 157 122 116 88 81 68
Invested Capital Turnover
0.03 0.03 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.01
Increase / (Decrease) in Invested Capital
-55 -0.42 -19 9.97 76 54 3.81 -14 -14 -43
Enterprise Value (EV)
563 548 658 684 600 573 627 691 958 951
Market Capitalization
622 571 700 735 623 610 677 778 1,064 1,079
Book Value per Share
$8.70 $7.77 $7.48 $8.01 $9.53 $8.39 $8.77 $9.22 $10.14 $10.65
Tangible Book Value per Share
($3.01) ($5.45) ($4.45) ($3.82) ($1.18) ($0.56) $0.35 $1.04 $1.91 $2.79
Total Capital
162 150 140 150 200 179 186 175 186 196
Total Debt
1.00 5.40 1.00 1.00 20 20 20 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-60 -23 -42 -51 -23 -37 -50 -86 -106 -128
Capital Expenditures (CapEx)
0.04 0.06 0.21 0.00 0.58 0.40 1.14 0.01 0.80 0.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-4.52 -7.52 -1.16 -1.55 4.63 3.88 2.06 2.91 0.51 -2.60
Debt-free Net Working Capital (DFNWC)
56 21 42 50 48 61 72 89 106 125
Net Working Capital (NWC)
55 16 41 49 28 41 52 89 106 125
Net Nonoperating Expense (NNE)
2.05 -0.46 3.58 5.02 -0.48 2.14 3.18 4.05 3.45 4.05
Net Nonoperating Obligations (NNO)
-60 -23 -42 -51 -23 -37 -50 -86 -106 -128
Total Depreciation and Amortization (D&A)
0.19 0.20 0.28 0.18 0.31 0.37 0.37 0.60 0.45 0.59
Debt-free, Cash-free Net Working Capital to Revenue
-107.80% -196.19% -34.74% -70.80% 241.06% 235.42% 141.84% 235.00% 47.14% -370.80%
Debt-free Net Working Capital to Revenue
1,337.63% 554.90% 1,254.62% 2,288.46% 2,491.30% 3,729.40% 4,967.31% 7,224.17% 9,791.05% 17,829.20%
Net Working Capital to Revenue
1,313.77% 414.14% 1,224.72% 2,242.84% 1,436.11% 2,499.21% 3,573.71% 7,224.17% 9,791.05% 17,829.20%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.51) $0.41 ($0.69) ($0.84) $0.82 ($0.42) ($0.56) ($0.71) ($0.60) ($0.69)
Adjusted Weighted Average Basic Shares Outstanding
18.77M 18.61M 18.59M 18.49M 18.84M 18.93M 18.95M 18.62M 18.14M 18.37M
Adjusted Diluted Earnings per Share
($0.51) $0.41 ($0.69) ($0.84) $0.82 ($0.42) ($0.56) ($0.71) ($0.60) ($0.69)
Adjusted Weighted Average Diluted Shares Outstanding
18.77M 18.78M 18.59M 18.49M 18.84M 18.93M 18.95M 18.62M 18.14M 18.37M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 ($0.69)
Adjusted Weighted Average Basic & Diluted Shares Outstanding
18.57M 18.59M 18.62M 18.59M 19.04M 18.87M 18.96M 18.94M 18.93M 18.31M
Normalized Net Operating Profit after Tax (NOPAT)
-8.75 -7.15 -9.19 -11 -13 -9.94 -9.48 -9.60 -8.25 -8.62
Normalized NOPAT Margin
-694.17% -456.30% -592.59% -689.08% -2,114.96% -1,719.84% -2,382.29% -2,866.45% -2,462.96% -2,239.64%
Pre Tax Income Margin
-757.22% 477.39% -808.25% -937.84% 2,661.02% -1,351.21% -2,620.10% -3,879.40% -3,207.16% -3,195.58%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-270.33% 80.61% -193.33% -104.94% -50.40% -26.10% -41.38% -45.70% -39.88% -32.04%

Frequently Asked Questions About Anterix's Financials

When does Anterix's financial year end?

According to the most recent income statement we have on file, Anterix's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

How has Anterix's net income changed over the last 2 years?

Anterix's net income appears to be on a downward trend, with a most recent value of -$9.13 million in 2024, falling from -$37.52 million in 2022. The previous period was -$16.32 million in 2023. Find out what analysts predict for Anterix in the coming months.

What is Anterix's operating income?
Anterix's total operating income in 2024 was -$10.12 million, based on the following breakdown:
  • Total Gross Profit: $4.19 million
  • Total Operating Expenses: $14.31 million
How has Anterix revenue changed over the last 2 years?

Over the last 2 years, Anterix's total revenue changed from $1.08 million in 2022 to $4.19 million in 2024, a change of 286.6%.

How much debt does Anterix have?

Anterix's total liabilities were at $163.86 million at the end of 2024, a 65.9% increase from 2023, and a 78.6% increase since 2022.

How much cash does Anterix have?

In the past 2 years, Anterix's cash and equivalents has ranged from $43.18 million in 2023 to $105.62 million in 2022, and is currently $60.58 million as of their latest financial filing in 2024.

How has Anterix's book value per share changed over the last 2 years?

Over the last 2 years, Anterix's book value per share changed from 10.14 in 2022 to 8.70 in 2024, a change of -14.2%.



This page (NASDAQ:ATEX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners